Skip to content

Reauthorization of the Prescription Drug User Fee Act and FDA reform

by United States. Congress. House. Committee on Commerce. Subcommittee on Health and the Environment.

Cover of Reauthorization of the Prescription Drug User Fee Act and FDA reform

No description available.

ManagementDrugsLaw and legislationUnited StatesPricesPrescription pricingUnited States. Food and Drug AdministrationDrugs, law and legislationDrugs, pricesUnited states, food and drug administration